A Republican amendment offered, then tabled, in the U.S. Senate Feb. 4-5 to a budget bill linked to Democrats’ forthcoming COVID-19 relief package could have led to Senate action related to “improving transparency” in the 340B program “through data reporting.”
…Category: Legislative
The bipartisan group of six U.S. House members that got 217 total representatives last fall—173 Democrats and 44 Republicans—to sign a letter opposing efforts to replace up-front 340B drug discounts with back-end rebates began circulating a new 340B sign-on letter
…U.S. Senate Democrats late Tuesday afternoon announced their committee assignments for the 117th Congress. Senate Republicans had not yet announced their committee members as of this morning. However, Sen. Richard Burr (N.C.) will be the ranking Republican on the Health,
…Forty-four New York state legislators have signed a letter to Gov. Andrew Cuomo (D) expressing “strong opposition” to the scheduled transfer in April of Medicaid managed care pharmacy benefits to Medicaid fee for service. They said the transfer “will have
…Humorist Bill Maher, host of HBO’s long-running Real Time with Bill Maher program, on Friday “honored” former U.S. House Energy and Commerce Chair Henry Waxman (D-Calif.) with a new award for unheralded public service—the Baldy. Waxman was a driving force
…U.S. Sen. Rob Portman (R-Ohio) announced yesterday he will not run for reelection in 2022. His retirement will deprive 340B covered entities of a reliable Senate Republican ally come 2023.
Although Portman is not on the Health, Education, Labor, and
…U.S. House Energy and Commerce (E&C) Chair Frank Pallone (D-N.J.) last Friday formally announced Rep. Anna Eshoo (D-Calif.) as Health subcommittee chair and Rep. Diana DeGette (D-Colo.) as leader of the Oversight and Investigations subcommittee.
Eshoo, who is based
…U.S. insulin manufacturer and pharmacy benefit manager (PBM) business practices “have created a vicious cycle of price increases that have sent costs for patients and taxpayers through the roof,” U.S. Senate Finance Committee leaders Chuck Grassley (R-Iowa) and Ron Wyden
…The incoming Democratic chairs of two key U.S. Senate committees want the federal agency in charge of the 340B program “to take immediate action to clarify that implementation of a rebate model by [drug] manufacturers would violate a material condition
…